BMC Immunology

official impact factor 3.00

Open Access Highly Access Email this article to a friend

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells

Elisabeth Ersvaer*, Knut Liseth, Jørn Skavland, Bjørn T Gjertsen and Øystein Bruserud

BMC Immunology 2010, 11:38 doi:10.1186/1471-2172-11-38

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.